(+)-schisandrin B multiple interactions ISO Cxxc5 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CXXC5 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CXXC5 mRNA CTD PMID:22079256 17alpha-ethynylestradiol multiple interactions ISO Cxxc5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXXC5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO Cxxc5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CXXC5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO Cxxc5 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of CXXC5 mRNA CTD PMID:17555576 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CXXC5 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CXXC5 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cxxc5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXXC5 mRNA and [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CXXC5 mRNA CTD PMID:17942748 and PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CXXC5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXXC5 mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cxxc5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of CXXC5 mRNA CTD PMID:22298810 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CXXC5 mRNA CTD PMID:30851411 2-methylcholine affects expression EXP 6480464 beta-methylcholine affects the expression of CXXC5 mRNA CTD PMID:21179406 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXXC5 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression ISO Cxxc5 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in increased expression of CXXC5 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol multiple interactions ISO Cxxc5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CXXC5 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO Cxxc5 (Mus musculus) 6480464 Fenretinide results in increased expression of CXXC5 mRNA CTD PMID:28973697 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of CXXC5 gene CTD PMID:27153756 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CXXC5 mRNA CTD PMID:15894607 and PMID:33167477 all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of CXXC5 mRNA CTD PMID:15894607 amphetamine decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Amphetamine results in decreased expression of CXXC5 mRNA CTD PMID:30779732 aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of CXXC5 mRNA CTD PMID:33212167 arsane increases methylation EXP 6480464 Arsenic results in increased methylation of CXXC5 promoter CTD PMID:21291286 arsenic atom increases methylation EXP 6480464 Arsenic results in increased methylation of CXXC5 promoter CTD PMID:21291286 arsenous acid multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CXXC5 mRNA CTD PMID:15894607 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of CXXC5 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of CXXC5 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 bisphenol A affects expression ISO Cxxc5 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CXXC5 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO Cxxc5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CXXC5 mRNA CTD PMID:36041667 bisphenol A increases expression ISO Cxxc5 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CXXC5 mRNA CTD PMID:32145629 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CXXC5 mRNA CTD PMID:29275510 bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXXC5 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO Cxxc5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CXXC5 mRNA CTD PMID:36041667 buta-1,3-diene decreases expression ISO Cxxc5 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of CXXC5 mRNA CTD PMID:29038090 CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CXXC5 gene] CTD PMID:28238834 chlorpyrifos increases expression ISO Cxxc5 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of CXXC5 mRNA CTD PMID:37019170 chromium(6+) decreases expression EXP 6480464 chromium hexavalent ion results in decreased expression of CXXC5 mRNA CTD PMID:30690063 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CXXC5 mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CXXC5 mRNA CTD PMID:27392435 cocaine affects expression ISO Cxxc5 (Rattus norvegicus) 6480464 Cocaine affects the expression of CXXC5 mRNA CTD PMID:20187946 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of CXXC5 mRNA CTD PMID:19549813 coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA CTD PMID:19167446 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CXXC5 mRNA CTD PMID:27989131 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXXC5 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CXXC5 mRNA CTD PMID:15894607 dibutyl phthalate increases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of CXXC5 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO Cxxc5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CXXC5 mRNA CTD PMID:17361019 and PMID:21266533 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of CXXC5 mRNA CTD PMID:18175754 diuron decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Diuron results in decreased expression of CXXC5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA CTD PMID:19167446 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXXC5 mRNA CTD PMID:27188386 entinostat increases expression EXP 6480464 entinostat results in increased expression of CXXC5 mRNA CTD PMID:26272509 epoxiconazole increases expression ISO Cxxc5 (Mus musculus) 6480464 epoxiconazole results in increased expression of CXXC5 mRNA CTD PMID:35436446 ethanol affects expression ISO Cxxc5 (Mus musculus) 6480464 Ethanol affects the expression of CXXC5 mRNA CTD PMID:30319688 ethanol affects splicing ISO Cxxc5 (Mus musculus) 6480464 Ethanol affects the splicing of CXXC5 mRNA CTD PMID:30319688 flutamide decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of CXXC5 mRNA CTD PMID:24136188 gallic acid decreases expression EXP 6480464 Gallic Acid results in decreased expression of CXXC5 mRNA CTD PMID:34408198 gentamycin decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CXXC5 mRNA CTD PMID:33387578 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of CXXC5 mRNA CTD PMID:21179406 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXXC5 mRNA CTD PMID:28628672 isobutanol multiple interactions EXP 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CXXC5 mRNA CTD PMID:29432896 isoprenaline decreases expression ISO Cxxc5 (Mus musculus) 6480464 Isoproterenol results in decreased expression of CXXC5 mRNA CTD PMID:20003209 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CXXC5 mRNA CTD PMID:28988120 lipopolysaccharide decreases expression ISO Cxxc5 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of CXXC5 mRNA CTD PMID:25890327 menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of CXXC5 mRNA CTD PMID:20044591 methoxychlor affects methylation ISO Cxxc5 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of CXXC5 gene CTD PMID:35440735 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CXXC5 mRNA CTD PMID:23179753 and PMID:26272509 nefazodone decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 nefazodone results in decreased expression of CXXC5 mRNA CTD PMID:24136188 nimesulide decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 nimesulide results in decreased expression of CXXC5 mRNA CTD PMID:24136188 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXXC5 mRNA CTD PMID:27188386 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of CXXC5 mRNA CTD PMID:26272509 paracetamol affects expression ISO Cxxc5 (Mus musculus) 6480464 Acetaminophen affects the expression of CXXC5 mRNA CTD PMID:17562736 paracetamol decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CXXC5 mRNA CTD PMID:33387578 paracetamol affects response to substance EXP 6480464 CXXC5 gene polymorphism affects the susceptibility to Acetaminophen CTD PMID:26104854 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CXXC5 mRNA CTD PMID:21420995 pentachlorophenol decreases expression ISO Cxxc5 (Mus musculus) 6480464 Pentachlorophenol results in decreased expression of CXXC5 mRNA CTD PMID:23892564 perfluorohexanesulfonic acid decreases expression EXP 6480464 perfluorohexanesulfonic acid results in decreased expression of CXXC5 mRNA CTD PMID:25812627 perfluorohexanesulfonic acid decreases expression ISO Cxxc5 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of CXXC5 mRNA CTD PMID:37995155 perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of CXXC5 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid multiple interactions ISO Cxxc5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CXXC5 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of CXXC5 mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in decreased expression of CXXC5 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CXXC5 mRNA CTD PMID:25812627 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CXXC5 mRNA CTD PMID:19159669 phenobarbital affects expression ISO Cxxc5 (Mus musculus) 6480464 Phenobarbital affects the expression of CXXC5 mRNA CTD PMID:23091169 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of CXXC5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXXC5 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 pirinixic acid results in decreased expression of CXXC5 mRNA CTD PMID:19162173 pirinixic acid decreases expression ISO Cxxc5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CXXC5 mRNA CTD PMID:20813756 and PMID:23811191 potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CXXC5 mRNA CTD PMID:22079256 potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of CXXC5 mRNA CTD PMID:22079256 and PMID:22714537 progesterone affects expression ISO Cxxc5 (Mus musculus) 6480464 Progesterone affects the expression of CXXC5 mRNA CTD PMID:17251523 propiconazole decreases expression ISO Cxxc5 (Mus musculus) 6480464 propiconazole results in decreased expression of CXXC5 mRNA CTD PMID:21278054 rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CXXC5 mRNA CTD PMID:30851411 rotenone increases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Rotenone results in increased expression of CXXC5 mRNA CTD PMID:19013527 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases expression EXP 6480464 Asbestos and Serpentine results in decreased expression of CXXC5 mRNA CTD PMID:21148743 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of CXXC5 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO Cxxc5 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of CXXC5 mRNA CTD PMID:19073995 sodium arsenate increases expression ISO Cxxc5 (Mus musculus) 6480464 sodium arsenate results in increased expression of CXXC5 mRNA CTD PMID:30953684 sodium fluoride increases expression ISO Cxxc5 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of CXXC5 mRNA CTD PMID:27862939 sodium fluoride multiple interactions ISO Cxxc5 (Mus musculus) 6480464 DKK1 protein inhibits the reaction [Sodium Fluoride results in decreased expression of CXXC5 protein] CTD PMID:36063856 sodium fluoride decreases expression ISO Cxxc5 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of CXXC5 mRNA and Sodium Fluoride results in decreased expression of CXXC5 protein CTD PMID:36063856 Soman decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Soman results in decreased expression of CXXC5 mRNA CTD PMID:19281266 tamoxifen affects expression ISO Cxxc5 (Mus musculus) 6480464 Tamoxifen affects the expression of CXXC5 mRNA CTD PMID:17555576 temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of CXXC5 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of CXXC5 mRNA CTD PMID:29432895 tetrachloromethane decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of CXXC5 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO Cxxc5 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CXXC5 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions ISO Cxxc5 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CXXC5 mRNA] CTD PMID:31150632 thioacetamide decreases expression ISO Cxxc5 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CXXC5 mRNA CTD PMID:23411599 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of CXXC5 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXXC5 mRNA CTD PMID:27188386 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CXXC5 mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CXXC5 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXXC5 mRNA CTD PMID:27188386 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of CXXC5 gene CTD PMID:29154799 vinclozolin affects expression ISO Cxxc5 (Rattus norvegicus) 6480464 vinclozolin affects the expression of CXXC5 mRNA CTD PMID:19015723 vorinostat increases expression EXP 6480464 vorinostat results in increased expression of CXXC5 mRNA CTD PMID:26272509 vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXXC5 mRNA CTD PMID:27188386